Impact of tenofovir antiviral treatment on survival of chronic hepatitis B related hepatocellular carcinoma after hepatectomy in Chinese individuals from Qingdao municipality

The impact of different antiviral regimen on prognosis of chronic hepatitis B (CHB) related hepatocellular carcinoma (HCC) remains to be explored. A total of 479 CHB-related HCC patients after curative liver resection were enrolled receiving tenofovir (TDF, TDF group) or lamivudine, telbivudine, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Zhong, Ma, Jian, Qiao, Bing, Wang, Yanling, Zhang, Haifeng, Gou, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593059/
https://www.ncbi.nlm.nih.gov/pubmed/32769872
http://dx.doi.org/10.1097/MD.0000000000021454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593059/
https://www.ncbi.nlm.nih.gov/pubmed/32769872
http://dx.doi.org/10.1097/MD.0000000000021454

Ejemplares similares